Renal Denervation Devices Market Cross USD 1.6 Billion by 2020

According to a market research report Renal Denervation Devices Market, 2013-2020 published by iHealthcareAnalyst, Inc., the global renal denervation devices market is estimated to reach USD 1.6 Billion in 2020, expanding at a CAGR of 26.4% from 2016 to 2020.

Visit the Renal Denervation Devices Market, 2013-2020 report at https://www.ihealthcareanalyst.com/report/renal-denervation-devices-market/

The global renal denervation devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Renal denervation is a minimal invasive procedure. It is used for the treatment of drug resistant or treatment resistant hypertension. This procedure reduces blood pressure by ablation of renal nerves. This procedure has certain benefits like shorter treatment timed permanent effects over drug treatment which in turn reduces the cost of treatment. These benefits tend to drive the market.

The global renal denervation devices market segmentation is based on technology (renal sympathetic denervation procedure, radiofrequency-based renal denervation system, ultrasound-based renal denervation system, micro-infusion catheter-based renal denervation system), product or brand types (Simplicity Renal Denervation System, EnligHTN Multi-Electrode Renal Denervation System, OneShot, V2 Renal denervation System, PARADISE Technology, Surround Sound Renal Denervation System, TIVUS, Bullfrog Mocro-Infusion Catheters, Sound 360). The global renal denervation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global renal denervation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Technology
1.1 Renal Sympathetic Denervation Procedure
1.2 Radiofrequency-based Renal Denervation System
1.3 Ultrasound-based Renal Denervation System
1.4 Micro-infusion Catheter-based Renal Denervation System

2. Product Type (Brand)
2.1 Simplicity Renal Denervation System
2.2 EnligHTN Multi-Electrode Renal Denervation System
2.3 OneShot
2.4 V2 Renal Denervation System
2.5 PARADISE Technology
2.6 Other Emerging Technologies
2.6.1 Surround Sound Renal Denervation System
2.6.2 TIVUS
2.6.3 Bullfrog Mocro-Infusion Catheters
2.6.4 Sound 360

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 Boston Scientific Corporation
4.2 CardioSonic
4.3 Covidien PLC
4.4 Kona Medical
4.5 Medtronics Inc.
4.6 Mercator Medsystems
4.7 St. Jude Medical

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.